Insiders · INKT

INKT insider transactions

MiNK Therapeutics Inc. (INKT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for INKT

• 3d
  Director Ryan Barbara sold $19,141 worth of shares (1,500 units at $12.76), decreasing direct ownership by 6% to 21,969 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 6d
  Director Ryan Barbara was granted 3,063 shares, increasing direct ownership by 15% to 23,469 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 6d
  Director Holcomb John Bradley was granted 2,330 shares, increasing direct ownership by 207% to 3,458 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 6d
  Director Corvese Brian was granted 3,084 shares, increasing direct ownership by 6% to 53,137 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 6d
  Director Behner Peter was granted 2,804 shares, increasing direct ownership by 14% to 22,919 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 6d
  Director Wiinberg Ulf was granted 2,416 shares, increasing direct ownership by 12% to 22,650 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 39d
  SEC Form 4 filed by Director Holcomb John Bradley

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 60d
  SEC Form 3 filed by new insider Orilall Melissa

  3 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 77d
  SEC Form 3 filed by new insider Charette Austin

  3 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 89d
  SEC Form 4 filed by MiNK Therapeutics Inc.

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 96d
  Director Ryan Barbara sold $5,426 worth of shares (500 units at $10.85), decreasing direct ownership by 2% to 21,906 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 145d
  Amendment: Chief Executive Officer Buell Jennifer covered exercise/tax liability with 10,024 shares, decreasing direct ownership by 15% to 57,942 units (SEC Form 4)

  4/A - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 153d
  Chief Executive Officer Buell Jennifer was granted 31,474 shares, increasing direct ownership by 86% to 67,966 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 153d
  SEC Form 4 filed by Director Wiinberg Ulf

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 153d
  SEC Form 4 filed by Director Ryan Barbara

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 153d
  SEC Form 4 filed by Director Corvese Brian

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 153d
  SEC Form 4 filed by Director Behner Peter

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 187d
  Director Holcomb John Bradley was granted 1,128 shares (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 187d
  Director Kadlec Robert Peter was granted 1,218 shares, increasing direct ownership by 7% to 19,126 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 187d
  Director Ryan Barbara was granted 1,601 shares, increasing direct ownership by 8% to 22,406 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 187d
  Director Wiinberg Ulf was granted 1,263 shares, increasing direct ownership by 7% to 20,234 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 187d
  Director Behner Peter was granted 1,466 shares, increasing direct ownership by 8% to 20,115 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 187d
  Director Corvese Brian was granted 1,612 shares, increasing direct ownership by 3% to 50,053 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 248d
  Amendment: Chief Executive Officer Buell Jennifer covered exercise/tax liability with 5,351 shares, decreasing direct ownership by 13% to 36,492 units (SEC Form 4)

  4/A - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 270d
  Chief Executive Officer Buell Jennifer was granted 18,229 shares, increasing direct ownership by 77% to 41,913 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 270d
  SEC Form 4 filed by Director Behner Peter

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 270d
  SEC Form 4 filed by Director Kadlec Robert Peter

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 270d
  SEC Form 4 filed by Director Wiinberg Ulf

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 270d
  SEC Form 4 filed by Director Ryan Barbara

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 270d
  SEC Form 4 filed by Director Corvese Brian

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 278d
  Director Wiinberg Ulf was granted 1,011 shares, increasing direct ownership by 6% to 18,971 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 278d
  Director Kadlec Robert Peter was granted 975 shares, increasing direct ownership by 6% to 17,908 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 278d
  Director Ryan Barbara was granted 1,281 shares, increasing direct ownership by 7% to 20,805 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 278d
  Director Corvese Brian was granted 1,290 shares, increasing direct ownership by 3% to 48,441 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 278d
  Director Behner Peter was granted 1,173 shares, increasing direct ownership by 7% to 18,649 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 369d
  Director Corvese Brian was granted 2,494 shares, increasing direct ownership by 6% to 47,151 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 369d
  Director Behner Peter was granted 2,267 shares, increasing direct ownership by 15% to 17,476 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 369d
  Director Kadlec Robert Peter was granted 1,883 shares, increasing direct ownership by 68% to 4,647 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 369d
  Director Wiinberg Ulf was granted 1,953 shares, increasing direct ownership by 12% to 17,960 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 369d
  Director Ryan Barbara was granted 2,476 shares, increasing direct ownership by 15% to 19,524 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 460d
  Director Kadlec Robert Peter was granted 1,536 shares, increasing direct ownership by 125% to 2,764 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 460d
  Director Behner Peter was granted 1,849 shares, increasing direct ownership by 14% to 15,209 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 460d
  Director Wiinberg Ulf was granted 1,593 shares, increasing direct ownership by 11% to 16,007 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 460d
  Director Corvese Brian was granted 2,033 shares, increasing direct ownership by 5% to 44,657 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 460d
  Director Ryan Barbara was granted 2,019 shares, increasing direct ownership by 13% to 17,048 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 546d
  Director Kadlec Robert Peter was granted 12,286 shares (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 546d
  SEC Form 3 filed by new insider Kadlec Robert Peter

  3 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 553d
  Director Ryan Barbara was granted 24,229 shares, increasing direct ownership by 19% to 150,336 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 553d
  Director Corvese Brian was granted 24,400 shares, increasing direct ownership by 6% to 426,283 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 553d
  Director Behner Peter was granted 20,987 shares, increasing direct ownership by 19% to 133,634 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 553d
  Director Wiinberg Ulf was granted 20,476 shares, increasing direct ownership by 17% to 144,181 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 642d
  Director Ryan Barbara was granted 21,649 shares, increasing direct ownership by 21% to 126,107 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 642d
  Director Behner Peter was granted 18,753 shares, increasing direct ownership by 21% to 109,234 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 642d
  Director Wiinberg Ulf was granted 18,295 shares, increasing direct ownership by 17% to 123,705 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 642d
  Director Corvese Brian was granted 21,802 shares, increasing direct ownership by 6% to 405,296 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 733d
  Behner Peter was granted 15,454 shares, increasing direct ownership by 21% to 90,481 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 733d
  Ryan Barbara was granted 17,841 shares, increasing direct ownership by 21% to 104,458 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 733d
  Wiinberg Ulf was granted 15,077 shares, increasing direct ownership by 17% to 105,410 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 733d
  Corvese Brian was granted 17,967 shares, increasing direct ownership by 5% to 383,494 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
• 825d
  Ryan Barbara was granted 18,685 shares, increasing direct ownership by 28% to 86,617 units (SEC Form 4)

  4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)